Share Twitter LinkedIn Facebook Email Jessica Geiger MD Of The Cleveland Clinic Discusses Recruiting Patients For KEYNOTE-630: Looking For Patients With High Risk Features Like A Primary Tumor Over 4cm & More Then 3 Nodes. Advertisement
TIL Therapy Breakthroughs for Oncologists and Oncology Professionals Melanoma Skin Cancer Treatment 1 Min Read
63% pCR Rate with Neoadjuvant Nivolumab + Relatlimab in Resectable Melanoma Melanoma Skin Cancer Treatment 4 Mins Read